|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Net revenues | ||||
| Cost of revenues | ||||
| Gross profit (loss) | ||||
| Operating income (expenses): | ||||
| Selling and marketing expenses | ||||
| General and administrative expenses | ||||
| Research and development expenses | ||||
| Change in fair value of cryptocurrencies | ||||
| Other income | ||||
| Total operating income (expenses) | ||||
| Profit (loss) from operations | ||||
| Finance expenses (income) | ||||
| Other income (expenses): | ||||
| Finance expenses | ||||
| Interest expense | ||||
| Interest income | ||||
| Change in fair value of borrowings denominated in cryptocurrencies | ||||
| Other income | ||||
| Other expenses | ||||
| Total other income (expenses) | ||||
| Income (loss) before income tax provision | ||||
| Income tax provision | ||||
| Net income (loss) | ||||
| Other comprehensive income (loss): | ||||
| Foreign currency translation adjustment | ||||
| Total comprehensive income (loss) | ||||
| Less: comprehensive loss attributable to noncontrolling interests | ||||
| Comprehensive income (loss) attributable to Nano Labs Ltd | ||||
| Net income (loss) per ordinary share attributable to Nano Labs Ltd | ||||
| –Basic (in Dollars per share and Yuan Renminbi per share) | ||||
| –Diluted (in Dollars per share and Yuan Renminbi per share) | ||||
| Weighted average number of shares used in per share calculation: | ||||
| – Basic (in Shares) | ||||
| – Diluted (in Shares) | ||||
| Less: net loss attributable to noncontrolling interests | ||||
| Net income (loss) attributable to Nano Labs Ltd | ||||
Loading...